Abstract
The effects of guanine nucleotides on binding of 8-cyclopentyl-1,3-3Hdipropylxanthine
(3HDPCPX), a highly selective A1 adenosine receptor antagonist,
have been investigated in rat brain membranes and solubilized A1
receptors. GTP, which induces uncoupling of receptors from guanine
nucleotide binding proteins, increased binding of 3HDPCPX in a
concentration-dependent manner. The rank order of potency for different
guanine nucleotides for increasing 3HDPCPX binding was the same
as for guanine nucleotide-induced inhibition of agonist binding.
Therefore, a role for a guanine nucleotide binding protein, e.g.,
Gi, in the regulation of antagonist binding is suggested. This was
confirmed by inactivation of Gi by N-ethylmaleimide (NEM) treatment
of membranes, which resulted in an increase in 3HDPCPX binding
similar to that seen with addition of GTP. Kinetic and equilibrium
binding studies showed that the GTP- or NEM-induced increase in antagonist
binding was not caused by an affinity change of A1 receptors for
3HDPCPX but by an increased Bmax value. Guanine nucleotides had
similar effects on membrane-bound and solubilized receptors, with
the effects in the solubilized system being more pronounced. In the
absence of GTP, when most receptors are in a high-affinity state
for agonists, only a few receptors are labeled by 3HDPCPX. It is
suggested that 3HDPCPX binding is inhibited when receptors are
coupled to Gi. Therefore, uncoupling of A1 receptors from Gi by guanine
nucleotides or by inactivation of Gi with NEM results in an increased
antagonist binding.
Users
Please
log in to take part in the discussion (add own reviews or comments).